Clinical characteristics
Age (years) 64.5±13.3
Males, n (%) 67(55.7%)
NYHA (class) 2±1
AFib, n (%) 34(32.1%)
CAD, n (%) 26(24.5%)
EF (%) 57±10
MV pathologies, n (%) 1.MR 2.MS 56(52.8%) 40(37.7%) 16(15.1%)
LV dilatation, n (%) 34(32.1%)
LA dilatation, n (%) 79(74.5%)
Indication for TOE
1.MV pathologies (MR+MS) 50(47.2%)
2.LAA evaluation 18(17%)
3.PFO assessment 11(10.4%)
4.Aortic stenosis 8(7.5%)
5. Other indications 19(17.9%)